Bastian Keck
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Cancer Immunotherapy and Biomarkers, Prostate Cancer Treatment and Research, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma(2016)645 cited
- → Toward the blood-borne miRNome of human diseases(2011)360 cited
- → The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes(2019)231 cited
- → MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening(2011)160 cited
- → Face-to-face vs. online peer support groups for prostate cancer: A cross-sectional comparison study(2017)128 cited
- → The plasmacytoid carcinoma of the bladder—rare variant of aggressive urothelial carcinoma(2010)115 cited
- → Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab(2018)102 cited
- → Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study(2017)93 cited
- → Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups(2018)91 cited
- → Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer(2022)87 cited